- Home
- BSBK vs COYA Comparison
BSBK vs COYA Comparison
Compare BSBK & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$4.25
Company Overview
Basic Information| Metric | BSBK | COYA |
|---|---|---|
| Founded | 1893 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.9M | 126.6M |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BSBK | COYA |
|---|---|---|
| Price | $8.45 | $4.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $15.80 |
| AVG Volume (30 Days) | 7.3K | ★ 155.7K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 200.00 | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | N/A | ★ $7,945,753.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $763.10 |
| P/E Ratio | $49.65 | ★ N/A |
| Revenue Growth | N/A | ★ 123.57 |
| 52 Week Low | $6.82 | $3.71 |
| 52 Week High | $9.49 | $7.75 |
Technical Indicators
Market Signals| Indicator | BSBK | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 49.12 | 46.84 |
| Support Level | $8.12 | $3.83 |
| Resistance Level | $8.64 | $5.16 |
| Average True Range (ATR) | 0.25 | 0.30 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 41.01 | 33.05 |
Price Performance
Historical Comparison BSBK
COYA
About BSBK Bogota Financial Corp.
Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from customers in New Jersey.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.